
Timing Your Cardio: How to Optimize Your Gym Routine for the Best Results
What are your fitness goals?
When it comes to deciding whether to do cardio or weights first during your workouts, it's a good idea to start with your goals. Do you want to lose weight or gain muscle tone? Maybe you want to improve your endurance or build bigger muscles.
One common misconception is that cardio is the most important exercise for losing weight, but both cardio and strength training are important for this.
Benefits of doing cardio before weights
Getty Images
Cardio is well-documented to be effective at burning calories. If you lift weights for 30 minutes versus doing any other cardio activity for the same amount of time, cardio will burn more calories. With that in mind, you may want to start your workouts with cardio at a steady intensity to get into the heart rate zone you need for burning fat. You can then transition into weight lifting, which will create an "afterburn," that helps burn calories after you're done exercising.
You don't even necessarily need to work your body hard to reap the benefits of a cardio workout. "Cardiovascular exercise at a lower intensity (in the fat burning zone/aerobic training zone) will help you to lose weight. [But] it needs to be sustained for longer periods of time," said Mollie Millington, a personal trainer based in London.
Lifting weights first, especially if you are lifting heavy using your entire body, will tire you out before you make it to the cardio portion of your workout. That means you might cut your workout short and not reap the calorie-burning benefit of cardio -- especially if you want to burn as many calories as you can in a set amount of time. Try both starting with cardio and starting with weight lifting to get a sense of what works best for you. If you are performing exercises with light weights, that can help get your heart rate up and get your body ready for running, biking or another cardio activity.
Lastly, if you like to run, bike or swim and want to improve your speed or overall endurance, then choosing cardio first is smart because you're going into those workouts fresh. This way you are starting with the most important exercise for your long-term goals and will make progress more quickly.
Benefits of doing weights before cardio
Getty Images
If your main goal is to improve your strength, be able to lift heavy things or build more muscle, then lifting weights first is best. Don't tire out your body by doing cardio first. The less tired you are, the more repetitions you'll be able to do with correct form -- and good form is crucial for performing strength training exercises safely and effectively.
Doing weights first may also be helpful for fat loss when combined with cardio, according to Millington. "In theory, doing weights first would put your body into aerobic mode [so] by the time you to get to running, you will already be in aerobic/fat burning state. So you may maintain [that aerobic state] longer while running and thus use fat as an energy source," Millington said. This is best when you are lifting lighter weights that don't fatigue your entire body.
Can you do cardio and weightlifting on the same day?
Finally, although science is pretty inconclusive about whether doing cardio or weights first is best, one very clear thing is that doing both is beneficial. Studies show that doing a combination of the two is best for overall health, increasing muscle and reducing body fat.
If you want to do both cardio and weight training at 100% effort, then you can try doing them on separate days, allowing your body to recover in between. If you prefer to do both at once, see what feels and works best for you.
"I am a firm believer in doing what you love. Exercise can be fun," Millington said. "If you are in the groove during your warm up on the treadmill and having fun, don't stop to do weights. Keep going until you are ready to change to weights. Or if you prefer weights to running, start off with a shorter run and then 'treat' yourself to weights," Millington said.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


CBS News
4 minutes ago
- CBS News
NYC Legionnaires' disease outbreak in Harlem leads to 2nd death. Here's what to know about the symptoms.
A Legionnaires' disease outbreak in New York City has led to at least 58 cases, including two reported deaths. The city's health department is now warning New Yorkers to be on the lookout for any flulike symptoms. Legionnaires' Disease is a severe form of pneumonia that can lead to cough, fever, chills and difficulty breathing. Health officials say the disease cannot be transmitted from person to person and can be treated with antibiotics. Complications are less likely the earlier treatment begins. Officials say 58 people have been diagnosed since July 25, and 21 cases were serious enough to lead to hospitalization. The outbreak is mostly contained to five zip codes across Central Harlem: 10027, 10030, 10035, 10037 and 10039. If you live in one of the zones and develop flulike symptoms, contact a health care provider immediately, especially if you're at higher risk, including those ages 50 and older and cigarette smokers. City officials believe the likely source of the bacteria causing the outbreak came from cooling towers in the affected communities. They ordered testing to be done and say the 11 that came back positive have all completed the remediation process.


Forbes
4 minutes ago
- Forbes
More Downside For Medtronic Stock?
Medtronic (NYSE:MDT), which is renowned for inventing the world's first battery-operated implantable pacemaker, has over time earned respect as a worldwide leader in medical technology and has created substantial value for its shareholders. Although the company's advancements have influenced contemporary healthcare, its stock presents a more cautious narrative today. Medtronic experienced a 50% decline in its stock from its 2021 peak of approximately $140 to below $70 in late 2023, partly attributed to the recall of its MiniMed 600 and 700 series insulin pumps over battery complications. While MDT stock has since regained some of those losses and currently boasts a market cap exceeding $100 billion, it still trades about 30% lower than that peak, prompting concerns regarding sustained investor faith. In the past year, Medtronic reported nearly $33.2 billion in revenue and $4.3 billion in net income, indicating slight top-line growth and consistent profitability. However, operating cash flow has been relatively weak and erratic, with only $127 million recorded in the latest quarter — a sum representing less than 0.5% of revenue and suggesting tighter cash generation despite stable earnings. What's not to appreciate? Here's the reality: in a downturn, MDT might still face significantly greater losses, and historical evidence supports this. In 2022, the stock declined nearly 49%, much more than the S&P 500. Therefore, could today's $93 stock dip below $50 if macroeconomic conditions worsen? It's a possibility. Of course, individual stocks tend to be more volatile compared to a diversified portfolio — and in this environment, if you desire potential gains with reduced volatility relative to a single stock, consider the High-Quality portfolio, which has outperformed the S&P 500 and achieved returns exceeding 91% since its inception. Why is this particularly important now? While Medtronic continues to innovate within its healthcare segment, current economic challenges may hold greater significance. Indeed, inflation pressures have eased, but they haven't vanished entirely. Moreover, growing uncertainty regarding global trade, interest rate strategies, and medical reimbursement trends could further strain healthcare profit margins. These risks heighten the likelihood of another downturn, or at least a more challenging environment for markets. When compounded with political and geopolitical uncertainties, it becomes clearer why a stock like Medtronic, despite its fundamental strengths, may find it difficult to reclaim its former highs. Here are the specific data points concerning Medtronic that raise our concerns: During the last two economic downturns, MDT stock lost significantly more value than the benchmark S&P 500 index (refer to the last six market crashes compared). Wealth Protection Here's the primary concern: Medtronic is still priced at a trailing P/E of approximately 27, despite experiencing slowing growth. Its LTM revenue growth has consistently slowed, from over 5% eight quarters ago to under 3% in the most recent quarter. So ask yourself: if the stock decreases to $70 or $50, will you maintain your position? Or will you panic sell? Maintaining a position in a falling stock is never easy. Trefis collaborates with Empirical Asset Management — a Boston-based wealth management firm — whose asset allocation strategies produced positive returns during the 2008-09 period when the S&P lost more than 40%. Empirical has included the Trefis HQ Portfolio within this asset allocation framework to offer clients better returns with lower risk compared to the benchmark index; this strategy is less of a roller-coaster experience, as evidenced by HQ Portfolio performance metrics.
Yahoo
32 minutes ago
- Yahoo
BD Businesses Become First in MedTech to Achieve HIRC's Diamond Badge Across All Supply Chain Resiliency Categories
FRANKLIN LAKES, N.J., Aug. 5, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that its Urology and Critical Care (UCC) and Surgery business units are the first in the medical technology industry to achieve a diamond-level rating for all seven supply chain resilience domains of the Healthcare Industry Resilience Collaborative's (HIRC) Resiliency Badging program. "Achieving HIRC's Diamond Status Resiliency Badge recognizes BD's commitment to building a resilient end-to-end supply chain across multiple product categories and our relentless pursuit of process excellence and continuous improvement," said Tony Ezell, executive vice president and president of the Americas region for BD. "Hundreds of millions of patients depend on BD, and this recognition is a testament to the work our team does every day to ensure products arrive on time and in the right quantities." HIRC is a non-profit health care supply chain trade association founded in 2019 by a group of health care systems and trading partners focused on increasing transparency and resiliency. The Resiliency Badge Program includes a rigorous audit to assess supply chain resiliency, ensuring alignment with HIRC's standards for supply continuity, risk mitigation and operational efficiency. After completing a comprehensive audit, HIRC recognized BD for differentiated resiliency in all domain areas for its Surgery and UCC businesses, including demand planning, supplier management, inventory management, logistics, supply chain visibility, risk management and continency planning, and operational health. BD was one of the first companies recognized by HIRC after receiving the Transparency Partner Badge in 2023. This diamond-level distinction builds on that recognition and demonstrates BD's ongoing investment in its supply chain and manufacturing operations, including increasing safety stock and capacity to allow greater flexibility for the most critical products and improving order management interfaces so customers have real-time insights into supply and deliveries. About BD BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit or connect with us on LinkedIn at X (formerly Twitter) @BDandCo or Instagram @becton_dickinson. Contacts: Media: Investors: Fallon McLoughlin Adam Reiffe BD Corporate Communications BD Investor Relations 201.258.0361 201.847.6927 View original content to download multimedia: SOURCE BD (Becton, Dickinson and Company) Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data